ARPICCO, Silvia Maria Angela
 Distribuzione geografica
Continente #
NA - Nord America 7.904
EU - Europa 5.191
AS - Asia 2.743
SA - Sud America 52
Continente sconosciuto - Info sul continente non disponibili 23
AF - Africa 21
OC - Oceania 21
Totale 15.955
Nazione #
US - Stati Uniti d'America 7.620
IT - Italia 1.440
CN - Cina 1.256
IE - Irlanda 753
SG - Singapore 617
DE - Germania 576
SE - Svezia 556
FR - Francia 434
FI - Finlandia 386
GB - Regno Unito 311
KR - Corea 295
UA - Ucraina 265
CA - Canada 263
PL - Polonia 140
JP - Giappone 127
AT - Austria 118
VN - Vietnam 109
IN - India 107
ID - Indonesia 69
ES - Italia 55
TW - Taiwan 34
RO - Romania 32
HK - Hong Kong 29
NL - Olanda 28
IR - Iran 24
RU - Federazione Russa 23
EU - Europa 22
BR - Brasile 21
MX - Messico 19
TR - Turchia 19
BE - Belgio 17
CO - Colombia 17
AU - Australia 16
CH - Svizzera 13
IL - Israele 10
MY - Malesia 10
PT - Portogallo 8
TH - Thailandia 8
GR - Grecia 7
CL - Cile 6
UZ - Uzbekistan 6
NG - Nigeria 5
NZ - Nuova Zelanda 5
AR - Argentina 4
CZ - Repubblica Ceca 4
EG - Egitto 4
IQ - Iraq 4
JO - Giordania 4
LT - Lituania 4
RS - Serbia 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
ZA - Sudafrica 4
PE - Perù 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CY - Cipro 2
DK - Danimarca 2
HU - Ungheria 2
LU - Lussemburgo 2
MA - Marocco 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
ZM - Zambia 1
Totale 15.955
Città #
Chandler 781
Dublin 741
Beijing 577
Santa Clara 542
Singapore 487
Fairfield 411
Ann Arbor 406
Torino 395
Houston 393
Ashburn 322
Jacksonville 269
Medford 225
Wilmington 221
Princeton 216
Villeurbanne 209
Woodbridge 206
Montréal 199
Columbus 196
Nyköping 178
Seattle 164
Dearborn 163
Munich 139
Cambridge 128
Warsaw 123
Vienna 115
Mcallen 107
Boston 94
Pisa 94
Redwood City 94
Turin 70
Milan 69
Dong Ket 63
Shanghai 63
Boardman 60
Jakarta 55
Rome 53
Fremont 50
Guangzhou 48
Nanjing 48
Hangzhou 41
Verona 41
Helsinki 38
Norwalk 34
San Diego 31
Hefei 30
New York 28
Zhengzhou 27
Shenyang 26
Taipei 26
Jinan 25
Tokyo 24
Toronto 23
Paris 21
Xian 20
Kunming 18
Lappeenranta 17
Chengdu 16
Falls Church 16
Erlangen 15
Hong Kong 15
Pune 15
Washington 15
Wuhan 14
Brussels 13
Fuzhou 13
Mumbai 13
Bologna 12
Hebei 12
Palermo 12
Upper Marlboro 12
Düsseldorf 11
London 11
Nanchang 11
Ottawa 11
Phoenix 11
Bogotá 10
Falkenstein 10
Harbin 10
Seoul 10
Ningbo 9
Palaiseau 9
Piemonte 9
Vancouver 9
Chicago 8
Dallas 8
Detroit 8
Kuala Lumpur 8
Lachine 8
Parma 8
Silver Spring 8
Berlin 7
Grafing 7
Mondavio 7
Mountain View 7
Padova 7
Philadelphia 7
Recife 7
San Mateo 7
Siena 7
Valencia 7
Totale 9.694
Nome #
Hyaluronated mesoporous silica nanoparticles for active targeting: influence of conjugation method and hyaluronic acid molecular weight on the nanovector properties 417
Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery 382
Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients 341
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 305
Validation of a simple and economic HPLC-UV method for the simultaneous determination of vancomycin, meropenem, piperacillin and tazobactam in plasma samples 299
Caratterizzazione di nanoparticelle di polialchilcianoacrilato coniugate con l’acido folico 261
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 257
Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes 206
Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model. 185
Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells 183
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells 183
Pentamidine-Loaded Lipid and Polymer Nanocarriers as Tunable Anticancer Drug Delivery Systems 179
Polysaccharide-coated liposomes by post-insertion of a hyaluronan-lipid conjugate 174
Hyaluronan-decorated liposomes as drug delivery systems for cutaneous administration 169
Preparazione e caratterizzazione di liposomi convenzionali ed a lunga circolazione contenenti taxani 167
Cell uptake and intracellular fate of phospholipidic manganese-based nanoparticles 164
Chemical and microbiological stability, anticoagulant efficacy and toxicity of 35 and 90 mM trisodium citrate solutions stored in plastic syringes 164
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 161
Advances in anticancer antibody-drug conjugates and immunotoxins. 157
Ruthenium polypyridyl squalene derivative: a novel self-assembling lipophilic probe for cellular imaging 154
Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives. 154
Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor 146
Hyaluronic acid-coated liposomes for active targeting of gemcitabine. 143
Peptide conjugation: before or after nanoparticle formation? 141
Rationally designed hyaluronic acid-based nano-complexes for pentamidine delivery 141
Synthesis of defined oligohyaluronates-decorated liposomes and interaction with lung cancer cells 136
Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes 125
Targeted Cancer Therapy: The Roles Played by Antibody-Drug and Antibody-Toxin Conjugates 124
SWCNT-porphyrin nano-hybrids selectively activated by ultrasound: an interesting model for sonodynamic applications 122
Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits 120
Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment 114
The role of conjugation processes and crosslinking agent in the preparation of molecular/particulate conjugates: a review 110
Supramolecular organization and siRNA binding of hyaluronic acid-coated lipoplexes for targeted delivery to the CD44 receptor. 109
Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells 105
Evaluation of the bactericidal activity of a hyaluronic acid-vehicled clarithromycin antibiotic mixture by confocal laser scanning microscopy 105
Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles 104
Preparazione e caratterizzazione di liposomi convenzionali e a lunga circolazione contenenti taxani 103
Preparation, characterization and properties in vitro and in vivo of a paclitaxel-albumin conjugate 102
Heteronanoparticles by self-Assembly of Doxorubicin and Cyclopamine Conjugates 101
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. 100
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 100
Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate 100
Anticancer prodrugs: an overview of major strategies and recent developments. 96
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases 95
Biological characterization of folic acid-conjugated poly(H(2)NPEGCA-co-HDCA) nanoparticles in cellular models 93
Immunotossine di nuova generazione: coniugati anticorpo monoclonale-tossina caratterizzati da elevata stabilità plasmatica e specifica attività antitumorale. 92
Delivery of gemcitabine prodrugs employing mesoporous silica nanoparticles 92
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain 92
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. 91
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 90
Characterisation of folic acid-nanoparticles conjugates for tumoral targeting 90
Disulfiram liposomiale: una nuova strategia contro l’adenocarcinoma duttale del pancreas. 90
New DSPE-PEG-Folate conjugates for liposomal drug targeting 86
Veicolazione del paclitaxel e di sue prodrugs idrofile in liposomi ed immunoliposomi. 86
Veicolazione di taxani in liposomi convenzionali ed a lunga circolazione 85
Hyaluronic acid for anticancer drug and nucleic acid delivery 84
Uptake and intracellular fate of biocompatible nanocarriers in cycling and noncycling cells 84
A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions 83
Biological characterisation of folic acid-conjugated nanoparticles in cellular models 81
Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization 80
Synthesis, characterization and biological evaluation of new PEG-paclitaxel derivatives. 80
Exploiting lipid and polymer nanocarriers to improve the anticancer sonodynamic activity of chlorophyll 80
PREPARATION AND CHARACTERIZATION OF LIPOSOMES CONTAINING A NEW ANTHRACYCLINE DERIVATIVE 79
Synthesis, characterization and biological activity of new cationic lipids active for gene transfection. 78
Cationic liposomes contaiing a DOPE-hyaluronate conjugate for gene delivery 78
SWCNT and graphene as meso-porphyrins delivery agents: synthetic approaches for Sono-Dynamic applications 78
Efficacy of a topical lotion containing lactoferricin, glycerophosphoinositol lysine and verbascoside for external otitis due to atopic dermatitis 78
Nonpolymeric nanoparticles for ocular administration of acyclovir 77
Veicolazione ed attività antitumorale di derivati della 5-fluorouridina mediante anticorpi monoclonali 77
Incorporation and release of gemcitabine prodrug in mesoporous silica nanoparticles 75
Identification of biological feature and of alternative therapeutic strategies for pancreatic cancer stem cells lines in 3D culture models. 75
Design of folic acid-conjugated nanoparticles for drug targeting 74
Transfezione genica con vettori non virali 74
Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery 74
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells 74
Developing actively targeted nanoparticles to fight cancer: Focus on italian research 74
Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization. 73
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 73
Incorporation and release of gemcitabine prodrug in mesoporous silica nanoparticles 73
Use of soluble paclitaxel prodrugs for novel liposomal formulations. 72
Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid 71
Cationic liposomes contaiing a DOPE-hyaluronic acid conjugate for gene delivery 71
Manganese-containing nanoparticles as potential MRI contrast agent: an in vitro study. 71
Characterisation of folic acid-conjugated nanoparticles for tumoral targeting 70
Chemioembolizzazione intraarteriosa con una nuova formulazione paclitaxel-lipiodol nel trattamento di neoplasie epatiche. 70
Detection of flourescent nanoparticles containing squalene-cyclopamine and squalene-paclitaxel 70
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids 69
Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery 69
Nanomedicine for gene delivery and drug repurposing in the treatment of muscular dystrophies 69
Hyaluronan liposomes for antitumor drug delivery 67
Preparation and characterization of novel PEG-paclitaxel derivatives 66
ANTITUMORAL ACTIVITY OF LIPOSOMES AND IMMUNOLIPOSOMES CONTAINING 5-FLUOROURIDINE PRODRUGS 66
Incorporation of lipophilic gemcitabine prodrugs in liposomes 65
Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape 65
An ex vivo experimental system to track fluorescent nanoparticles inside skeletal muscle 64
Ciblage tumorale intracellulaire à l’aide de l’acide folique couplé aux nanoparticules ‘peggylées’ 64
INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER 64
Single-step purification of immunotoxins containing a high-anionic charge ribosome-inactivating protein clavin by carboxymethyl high-performance membrane chromatography 63
Preparation, characterization, cytotoxicity and pharmacokinetcs of liposomes containing lipophilic gemcitabine prodrugs 63
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine 63
Totale 11.559
Categoria #
all - tutte 50.377
article - articoli 0
book - libri 0
conference - conferenze 19.581
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.357 0 0 0 0 0 350 246 143 235 188 123 72
2020/20211.942 236 99 118 77 147 116 229 114 227 188 173 218
2021/20222.221 87 85 89 153 121 78 183 157 85 106 602 475
2022/20232.737 270 151 55 247 222 725 311 169 283 77 150 77
2023/20241.361 138 238 83 72 96 137 57 77 15 114 130 204
2024/20251.832 65 245 128 305 883 206 0 0 0 0 0 0
Totale 16.549